PATENT CLAIM ANALYSIS

Application Number: 15947343
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["514", "221000"]

Abstract:
Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and neurological disorders, including, but not limited to, e.g., psychosis, schizophrenia, depression, movement disorders, and Parkinson's disease.

Claim (Index 48):
The method of  claim 43 , wherein the disorder is posttraumatic stress disorder, behavior disorder, neurodegenerative disease, Alzheimer's disease, dementia, mood disorder, anxiety, obsessive-compulsive disorder, vertigo, pain, neuropathic pain, sensitization accompanying neuropathic pain, inflammatory pain, fibromyalgia, migraine, cognitive disorder, cognitive impairment, cognitive impairment associated with schizophrenia, cognitive deficit in Alzheimer's disease, cognitive deficit in Parkinson's disease, multiple sclerosis, sleep disorder, eating disorder, or autism.

Metadata:
- Claim Count in Document: 100.0
- Percentile: 91.0
- Lexical Diversity: 1.65217
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14399334', '14950834', '15298469', '14884397', '14377673']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8094471082886693
- 35 USC 102 Novelty (BERT): 0.5924851242864292
- Combined Prediction Score: 0.7877509098884453
- Mean Citation Score: 390.945736
- Max Citation Score: 549.93964
- Similarity Product: 423.5035329989481

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test